Mexico is intensifying its efforts to combat a resurgence of measles, a highly contagious and potentially dangerous disease. The Instituto Mexicano del Seguro Social (IMSS) recently concluded an intensive vaccination campaign, administering over 670,000 doses of the measles vaccine over a weekend in February. This initiative underscores the growing concern over rising case numbers and the urgent need to protect vulnerable populations across the country. The campaign focused on 11 priority states, aiming to bolster protection for both children and young adults, and contribute to the national coverage goals set for 2026.
The recent surge in measles cases prompted the IMSS to launch this targeted vaccination drive. According to data from the Secretaría de Salud (SSA), as of February 23, 2026, Mexico has reported 10,941 cases of measles nationwide, tragically resulting in 32 fatalities associated with the illness. Saludiario reports that this intensive effort represents a significant step in the country’s strategy to mitigate the spread of the disease and prevent further loss of life.
IMSS Vaccination Campaign: A Weekend of Action
The intensive vaccination weekend, held on February 21st and 22nd, saw a massive mobilization of resources and personnel. The IMSS deployed 1,704 vaccination brigades, comprised of over 11,000 institutional staff and volunteers, supported by more than 3,000 medical units and vaccination centers. A total of 2.4 million doses of the measles vaccine were distributed to ensure sufficient supply at all vaccination sites. Dr. Ernesto Krug Llamas, Coordinator of First Level Units at IMSS, emphasized the significance of this coordinated effort in achieving widespread coverage.
The distribution of doses was strategically focused on areas with the greatest need. Specifically, 60,274 doses were administered in Mexico City, 3,601 in Colima, 25,592 in Chiapas, 10,997 in Durango, 26,175 in Jalisco, 6,240 in Nayarit, 55,132 in Puebla, 12,930 in Sinaloa, 18,437 in Sonora, 16,235 in Tabasco, and 4,888 in Tlaxcala. This targeted approach reflects a data-driven strategy to address regional variations in measles incidence and vaccination rates.
Progress Towards National Vaccination Goals
The IMSS vaccination campaign is part of a broader national effort to achieve comprehensive measles coverage. The Sistema Nacional de Salud has tasked the IMSS with vaccinating 13,513,565 people by 2026. This target includes 4,893,053 children aged six months to 12 years and 8,620,512 individuals between the ages of 13 and 49. OEM reports that the IMSS has already achieved 4.5% of its institutional goal for childhood vaccination over the next ten weeks, with 219,732 doses administered to children aged six months to 12 years and 450,710 doses given to individuals aged 13 to 49.
Measles is a highly contagious viral infection that can lead to serious complications, including pneumonia, encephalitis (brain swelling), and even death. Vaccination remains the most effective way to prevent the spread of the disease. The measles, mumps, and rubella (MMR) vaccine is typically administered in two doses, providing long-lasting immunity. The IMSS is urging individuals to check their national health card (Cartilla Nacional de Salud) to verify their vaccination status. Those without a record of two doses should seek vaccination at their nearest medical facility.
Finding Vaccination Locations and Staying Informed
The IMSS has made it easy for the public to locate vaccination sites. Individuals can find a list of active vaccination locations on the platform dondemevacuno.salud.gob.mx. This online resource provides up-to-date information on available vaccination centers, ensuring that individuals can access the vaccine conveniently. The campaign utilized a wide range of medical facilities, including 1,115 Family Medicine Units (UMF), 1,655 Rural Medical Units (UMR) operating on weekends, 21 High Specialty Medical Units (UMAE), 159 hospitals, 28 cultural and recreational facilities, and 104 vaccination centers in prominent or high-traffic locations.
Dr. Krug Llamas explained that the protective effects of the vaccine begin to develop within 15 to 21 days, as the body builds antibodies. While immediate protection is offered through “viral blocking,” long-term immunity is a gradual process. The IMSS is closely monitoring the impact of the vaccination campaign, anticipating a reduction in measles outbreaks in the coming weeks.
The Importance of Continued Vigilance
The success of this vaccination campaign hinges on continued public participation and vigilance. Health officials emphasize that maintaining high vaccination rates is crucial to achieving herd immunity, which protects even those who cannot be vaccinated, such as infants too young to receive the MMR vaccine or individuals with certain medical conditions. The IMSS’s commitment to providing widespread access to the measles vaccine demonstrates its dedication to safeguarding public health and preventing the resurgence of this preventable disease.
The recent measles outbreak serves as a stark reminder of the importance of vaccination in protecting communities from infectious diseases. By working together and prioritizing vaccination, Mexico can effectively control the spread of measles and ensure a healthier future for all its citizens. The IMSS will continue to monitor the situation closely and adapt its strategies as needed to address evolving public health challenges.
The next update on the national measles vaccination campaign is expected in early April 2026, when the Secretaría de Salud will release updated data on case numbers and vaccination coverage rates. We encourage readers to share this information with their communities and to prioritize vaccination against measles. Please leave your comments and questions below, and let’s continue the conversation about public health and disease prevention.